Abstract:Pharmacological interventions for effective treatment require opportune, dynamic and accurate manifestation of pathological status. Traditional clinical techniques relying on biopsy-based histological examinations and blood tests are dramatically restricted due to their invasiveness, unsatisfactory precision, non-real-time reporting and risk of complications. Although current strategies through molecular imaging enable non-invasive and spatiotemporal mapping of pathological changes in intact organisms, environment-activatable, sensitive and quantitative sensing platforms, especially for dynamic feedback of the therapeutic response, are still urgently desired in practice. Herein, we innovatively integrate deep-tissue penetrable multispectral optoacoustic tomography (MSOT) and near-infrared (NIR) optical imaging based technology by tailoring a free radical-responsive chromophore with photon-upconverting nanocrystals. During the therapeutic process, the specific reactions between the drug-stimulated reactive oxygen species (ROS) and radical-sensitive probes result in an absorption shift, which can be captured by MSOT. Meanwhile, the radical-triggered reaction also induces multispectral upconversion luminescence (UCL) responses that exhibit the opposite trend in comparison to MSOT. Such reversed-ratiometric dual-modal imaging outcomes provide an ideal cross-referencing system that guarantees the maximum sensing specificity and sensitivity, thus enabling precise disease biology evaluation and treatment assessments in vivo.

Amplification of Activated Near-Infrared Afterglow Luminescence by Introducing Twisted Molecular Geometry for Understanding Neutrophil-Involved Diseases

A Chemiluminescent Reporter Assisted by In-Situ Neutrophils for Imaging O2- at Inflammatory Sites.

Highly Sensitive Near-Infrared Imaging Of Peroxynitrite Fluxes In Inflammation Progress

Ratiometric afterglow luminescent nanoplatform enables reliable quantification and molecular imaging

Using Ultrafast Responsive Phosphorescent Nanoprobe to Visualize Elevated Peroxynitrite In Vitro and In Vivo via Ratiometric and Time-Resolved Photoluminescence Imaging

Oxygen-Embedded Pentacene Based Near-Infrared Chemiluminescent Nanoprobe for Highly Selective and Sensitive Visualization of Peroxynitrite in Vivo

Near-infrared chemiluminescent nanoprobes for deep imaging and synergistic photothermal-nitric-oxide therapy of bacterial infection

Chemiluminescent Probes with Long‐Lasting High Brightness for in Vivo Imaging of Neutrophils

A Chemiluminescent Probe for Imaging Peroxynitrite in Inflammatory Cells and Tissues

Peroxynitrite-activated Fluorescent Probe with Two Reaction Triggers for Pathological Diagnosis and Therapeutic Evaluation of Inflammation

Real-Time Mapping of Ultratrace Singlet Oxygen in Rat During Acute and Chronic Inflammations Via a Chemiluminescent Nanosensor.

A Self‐Sustaining Near‐Infrared Afterglow Chemiluminophore for High‐Contrast Activatable Imaging

Construction of a Robust Turn-on Fluorescence NIR Sensor for Rapid Detection and Imaging of ONOO− in Inflammatory Models

A Bioluminescent Probe for Imaging Endogenous Peroxynitrite in Living Cells and Mice

Shedding light on ONOO− detection: the emergence of a fast-response fluorescent probe for biological systems

NIR nanoprobe-facilitated cross-referencing manifestation of local disease biology for dynamic therapeutic response assessment

Activatable Fluorescent Nanoprobe with Aggregation-Induced Emission Characteristics for Selective In Vivo Imaging of Elevated Peroxynitrite Generation.

A Ratiometric Fluorescent Probe Activated by Neutrophil Elastase As a Novel Strategy for Early Tumor Diagnosis

A Biocompatible Probe for the Detection of Neutrophil Elastase Free from the Interference of Structural Changes and Its Application to Ratiometric Photoacoustic Imaging in Vivo.

A New Polymer Nanoprobe Based On Chemiluminescence Resonance Energy Transfer For Ultrasensitive Imaging Of Intrinsic Superoxide Anion In Mice

Cyclic Amplification of the Afterglow Luminescent Nanoreporter Enables the Prediction of Anti‐cancer Efficiency